| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives
|
Milani, A.
|
|
|
24 |
7 |
p. 1740-1748
|
article
|
| 2 |
Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival
|
Garbay, D.
|
|
|
24 |
7 |
p. 1924-1930
|
article
|
| 3 |
‘All action no talk’: the role of HER2/neu in adjuvant therapy choice for gastric cancer
|
Santini, D.
|
|
|
24 |
7 |
p. 1715-1717
|
article
|
| 4 |
Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)
|
Loriot, Y.
|
|
|
24 |
7 |
p. 1807-1812
|
article
|
| 5 |
A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer
|
Tolaney, S.M.
|
|
|
24 |
7 |
p. 1841-1847
|
article
|
| 6 |
A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II
|
Harvey, V.J.
|
|
|
24 |
7 |
p. 1828-1834
|
article
|
| 7 |
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer †
|
Cohn, A.L.
|
|
|
24 |
7 |
p. 1777-1785
|
article
|
| 8 |
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial
|
Gordon, M.A.
|
|
|
24 |
7 |
p. 1754-1761
|
article
|
| 9 |
Attitudes of patients with metastatic breast cancer toward research biopsies
|
Seah, D.S.
|
|
|
24 |
7 |
p. 1853-1859
|
article
|
| 10 |
Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers
|
Brouckaert, O.
|
|
|
24 |
7 |
p. 1847-1852
|
article
|
| 11 |
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide
|
Noonan, K.L.
|
|
|
24 |
7 |
p. 1802-1807
|
article
|
| 12 |
Coffee consumption and risk of localized, advanced and fatal prostate cancer: a population-based prospective study
|
Discacciati, A.
|
|
|
24 |
7 |
p. 1912-1918
|
article
|
| 13 |
Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial
|
Goossens, G.A.
|
|
|
24 |
7 |
p. 1892-1899
|
article
|
| 14 |
Cruciferous vegetables consumption and the risk of female lung cancer: a prospective study and a meta-analysis
|
Wu, Q.J.
|
|
|
24 |
7 |
p. 1918-1924
|
article
|
| 15 |
Editorial board
|
|
|
|
24 |
7 |
p. ii-iii
|
article
|
| 16 |
Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study
|
Guerrieri-Gonzaga, A.
|
|
|
24 |
7 |
p. 1859-1866
|
article
|
| 17 |
Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer †
|
van Dijk, T.H.
|
|
|
24 |
7 |
p. 1762-1769
|
article
|
| 18 |
FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study
|
Brodowicz, T.
|
|
|
24 |
7 |
p. 1769-1777
|
article
|
| 19 |
Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation
|
Weng, L.
|
|
|
24 |
7 |
p. 1867-1873
|
article
|
| 20 |
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer †
|
Wolpin, B.M.
|
|
|
24 |
7 |
p. 1792-1801
|
article
|
| 21 |
Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications
|
Raad, I.I.
|
|
|
24 |
7 |
p. 1873-1879
|
article
|
| 22 |
Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group
|
Wästerlid, T.
|
|
|
24 |
7 |
p. 1879-1886
|
article
|
| 23 |
Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?
|
Buchegger, F.
|
|
|
24 |
7 |
p. 1948-1949
|
article
|
| 24 |
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
|
Slovin, S.F.
|
|
|
24 |
7 |
p. 1813-1821
|
article
|
| 25 |
Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer? †
|
Skedgel, C.
|
|
|
24 |
7 |
p. 1834-1840
|
article
|
| 26 |
Non-inferiority cancer clinical trials: scope and purposes underlying their design
|
Riechelmann, R.P.
|
|
|
24 |
7 |
p. 1942-1947
|
article
|
| 27 |
Performance of multinomial designs in comparison with response-based designs in non-randomized phase II trials of targeted cancer agents
|
Jamal, R.
|
|
|
24 |
7 |
p. 1936-1942
|
article
|
| 28 |
Phase II study on lapatinib in advanced EGFR-positive chordoma †
|
Stacchiotti, S.
|
|
|
24 |
7 |
p. 1931-1936
|
article
|
| 29 |
Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas
|
Larghi, A.
|
|
|
24 |
7 |
p. 1907-1911
|
article
|
| 30 |
Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia
|
Ludwig, H.
|
|
|
24 |
7 |
p. 1886-1892
|
article
|
| 31 |
ROS1 fusions in Chinese patients with non-small-cell lung cancer
|
Cai, W.
|
|
|
24 |
7 |
p. 1822-1827
|
article
|
| 32 |
Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients
|
Zhao, Y.
|
|
|
24 |
7 |
p. 1786-1792
|
article
|
| 33 |
Spin and bias: the tip of the iceberg
|
Berger, V.W.
|
|
|
24 |
7 |
p. 1949
|
article
|
| 34 |
Spin and bias: the tip of the iceberg
|
Vera-Badillo, F.E.
|
|
|
24 |
7 |
p. 1949-1950
|
article
|
| 35 |
Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis
|
Singh, P.P.
|
|
|
24 |
7 |
p. 1721-1730
|
article
|
| 36 |
Table of Contents
|
|
|
|
24 |
7 |
p. iv-vi
|
article
|
| 37 |
Targeted therapies and the treatment of non-clear cell renal cell carcinoma
|
Bellmunt, J.
|
|
|
24 |
7 |
p. 1730-1740
|
article
|
| 38 |
Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates
|
Kelley, R.K.
|
|
|
24 |
7 |
p. 1900-1907
|
article
|
| 39 |
Therapeutic windows and opportunity cost cast upon prostate cancer's fatal shore
|
Goldkorn, A.
|
|
|
24 |
7 |
p. 1717-1720
|
article
|
| 40 |
The volume effect in paediatric oncology: a systematic review
|
Knops, R.R.G.
|
|
|
24 |
7 |
p. 1749-1753
|
article
|
Journal description